Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B (original) (raw)
Tang LSY, Covert E, Wilson E et al. Chronic hepatitis B infection: a Review. Jama. 2018;319:1802–1813. CASPubMed Google Scholar
Kim BS, Seo YS, Kim YS et al. Reduced risk of hepatocellular carcinoma by achieving a subcirrhotic liver stiffness through antiviral agents in hepatitis B virus-related advanced fibrosis or cirrhosis. J Gastroenterol Hepatol. 2018;33:503–510. CASPubMed Google Scholar
Kim SU, Seo YS, Lee HA et al. Hepatocellular carcinoma risk steadily persists over time despite long-term antiviral therapy for hepatitis B: a multicenter study. Cancer Epidemiol Biomark Prev. 2020;29:832–837. CAS Google Scholar
Schweitzer A, Horn J, Mikolajczyk RT et al. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386:1546–1555. PubMed Google Scholar
Cho EJ, Kim SE, Suk KT et al. Current status and strategies for hepatitis B control in Korea. Clin Mol Hepatol. 2017;23:205–211. PubMedPubMed Central Google Scholar
Hanouneh IA, Alkhouri N, Singal AG. Hepatocellular carcinoma surveillance in the 21st century: saving lives or causing harm? Clin Mol Hepatol. 2019;25:264–269. PubMedPubMed Central Google Scholar
Kim SU, Seo YS, Lee HA et al. A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in South Korea. J Hepatol. 2019;71:456–464. CASPubMed Google Scholar
Wei MT, Henry L, Nguyen MH. Nonliver comorbidities in patients with chronic hepatitis B. Clin Liver Dis (Hoboken). 2019;14:126–130. PubMedPubMed Central Google Scholar
Anonymous. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392:1736–1788. Google Scholar
Mendis S, Abegunde D, Yusuf S et al. WHO study on prevention of recurrences of myocardial infarction and stroke (WHO-PREMISE). Bull World Health Organ. 2005;83:820–829. PubMedPubMed Central Google Scholar
Han E, Lee YH, Kim YD et al. Nonalcoholic fatty liver disease and sarcopenia are independently associated with cardiovascular risk. Am J Gastroenterol. 2020;115:584–595. PubMed Google Scholar
Kiechl S, Egger G, Mayr M et al. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation. 2001;103:1064–1070. CASPubMed Google Scholar
Petta S, Maida M, Macaluso FS et al. Hepatitis C Virus infection is associated with increased cardiovascular mortality: a meta-analysis of observational studies. Gastroenterology. 2016;150:145–155. PubMed Google Scholar
Ungprasert P, Srivali N, Kittanamongkolchai W. Risk of coronary artery disease in patients with ankylosing spondylitis: a systematic review and meta-analysis. Ann Transl Med. 2015;3:51. PubMedPubMed Central Google Scholar
Ungprasert P, Suksaranjit P, Spanuchart I et al. Risk of coronary artery disease in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis of observational studies. Semin Arthritis Rheum. 2014;44:63–67. PubMed Google Scholar
Anonymous KASL. Clinical practice guidelines for management of chronic hepatitis B. Clin Mol Hepatol. 2019;25:93–159. Google Scholar
Jarčuška P, Janičko M, Kružliak P et al. Hepatitis B virus infection in patients with metabolic syndrome: a complicated relationship. Results of a population based study. Eur J Intern Med. 2014;25:286–291. PubMed Google Scholar
Wong GL, Chan HL, Yu Z et al. Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B–a prospective cohort study with paired transient elastography examinations. Aliment Pharmacol Ther. 2014;39:883–893. CASPubMed Google Scholar
Zhang J, Shen Y, Cai H et al. Hepatitis B virus infection status and risk of type 2 diabetes mellitus: a meta-analysis. Hepatol Res. 2015;45:1100–1109. PubMed Google Scholar
Jarcuska P, Drazilova S, Fedacko J et al. Association between hepatitis B and metabolic syndrome: current state of the art. World J Gastroenterol. 2016;22:155–164. CASPubMedPubMed Central Google Scholar
Wang CC, Hsu CS, Liu CJ et al. Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis. J Gastroenterol Hepatol. 2008;23:779–782. PubMed Google Scholar
Ishizaka N, Ishizaka Y, Takahashi E et al. Increased prevalence of carotid atherosclerosis in hepatitis B virus carriers. Circulation. 2002;105:1028–1030. PubMed Google Scholar
Targher G, Bertolini L, Padovani R et al. Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C. J Hepatol. 2007;46:1126–1132. CASPubMed Google Scholar
Moritani M, Adachi K, Arima N et al. A study of arteriosclerosis in healthy subjects with HBV and HCV infection. J Gastroenterol. 2005;40:1049–1053. PubMed Google Scholar
Tong DY, Wang XH, Xu CF et al. Hepatitis B virus infection and coronary atherosclerosis: results from a population with relatively high prevalence of hepatitis B virus. World J Gastroenterol. 2005;11:1292–1296. PubMedPubMed Central Google Scholar
Amin J, Law MG, Bartlett M et al. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet. 2006;368:938–945. PubMed Google Scholar
Kim Y, Choi S, Chun C et al. Data resource profile: the Korea youth risk behavior web-based survey (KYRBS). Int J Epidemiol. 2016;45:1076–1076e. PubMed Google Scholar
Jeon MY, Kim BK, Kim SU. Assessment of fibrotic burden among chronic hepatitis B virus-infected patients with normal transaminase level. Clin Mol Hepatol. 2018;24:367–369. PubMedPubMed Central Google Scholar
Castera L. Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: non-invasive tests are enough. Liver Int. 2018;38:67–70. PubMed Google Scholar
Shah AG, Lydecker A, Murray K et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009;7:1104–1112. CASPubMedPubMed Central Google Scholar
Huang X, Xu M, Chen Y et al. Validation of the fatty liver index for nonalcoholic fatty liver disease in middle-aged and elderly Chinese. Medicine (Baltimore). 2015;94:e1682. CASPubMedPubMed Central Google Scholar
Lee YH, Bang H, Park YM et al. Non-laboratory-based self-assessment screening score for non-alcoholic fatty liver disease: development, validation and comparison with other scores. PLoS One. 2014;9:e107584. PubMedPubMed Central Google Scholar
Sterling RK, Lissen E, Clumeck N et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006;43:1317–1325. CASPubMed Google Scholar
Mallet V, Dhalluin-Venier V, Roussin C et al. The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis B. Aliment Pharmacol Ther. 2009;29:409–415. CASPubMed Google Scholar
Angulo P, Hui JM, Marchesini G et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45:846–854. CASPubMed Google Scholar
Forns X, Ampurdanès S, Llovet JM et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology. 2002;36:986–992. PubMed Google Scholar
Bottero J, Lacombe K, Guéchot J et al. Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patients. J Hepatol. 2009;50:1074–1083. CASPubMed Google Scholar
Wong GL, Wong VW, Choi PC et al. Development of a non-invasive algorithm with transient elastography (Fibroscan) and serum test formula for advanced liver fibrosis in chronic hepatitis B. Aliment Pharmacol Ther. 2010;31:1095–1103. PubMed Google Scholar
Han E, Lee YH, Kim BK et al. Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B. Aliment Pharmacol Ther. 2018;48:300–312. CASPubMed Google Scholar
Bedogni G, Bellentani S, Miglioli L et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33. PubMedPubMed Central Google Scholar
Zhang Z, Wang G, Kang K et al. Diagnostic accuracy and clinical utility of a new noninvasive index for hepatic steatosis in patients with hepatitis B virus infection. Sci Rep. 2016;6:32875. CASPubMedPubMed Central Google Scholar
Andrus B, Lacaille D. 2013 ACC/AHA guideline on the assessment of cardiovascular risk. J Am Coll Cardiol. 2014;63:2886. PubMed Google Scholar
Stewart J, Manmathan G, Wilkinson P. Primary prevention of cardiovascular disease: a review of contemporary guidance and literature. JRSM Cardiovasc Dis. 2017;6:2048004016687211. PubMedPubMed Central Google Scholar
Lee YH, Kim SU, Song K et al. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008–2011). Hepatology. 2016;63:776–786. CASPubMed Google Scholar
Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Circulation. 2005;112:2735–2752. PubMed Google Scholar
Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419. CASPubMed Google Scholar
World Health Organization. The Asia-Pacific perspective: redefining obesity and its treatment. 2000.
Eslam M, Newsome PN, Sarin SK et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73:202–209. PubMed Google Scholar
Studenski SA, Peters KW, Alley DE et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69:547–558. PubMedPubMed Central Google Scholar
Ranasinghe P, Mathangasinghe Y, Jayawardena R et al. Prevalence and trends of metabolic syndrome among adults in the asia-pacific region: a systematic review. BMC Public Health. 2017;17:101. CASPubMedPubMed Central Google Scholar
Kim BK, Revill PA, Ahn SH. HBV genotypes: relevance to natural history, pathogenesis and treatment of chronic hepatitis B. Antivir Ther. 2011;16:1169–1186. CASPubMed Google Scholar
Machado MV, Oliveira AG, Cortez-Pinto H. Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients. J Gastroenterol Hepatol. 2011;26:1361–1367. PubMed Google Scholar
Hiraoka A, Michitaka K, Ueki H et al. Sarcopenia and two types of presarcopenia in Japanese patients with chronic liver disease. Eur J Gastroenterol Hepatol. 2016;28:940–947. PubMed Google Scholar
Ostovaneh MR, Ambale-Venkatesh B, Fuji T et al. Association of liver fibrosis with cardiovascular diseases in the general population: the multi-ethnic study of atherosclerosis (MESA). Circ Cardiovasc Imaging. 2018;11:e007241. PubMedPubMed Central Google Scholar
Yuan W, Lu HZ, Mei X et al. Cardiac health in patients with hepatitis B virus-related cirrhosis. Medicine (Baltimore). 2019;98:e14961. PubMedPubMed Central Google Scholar
Butt AA, Yan P, Aslam S et al. Liver fibrosis progression and mortality in hepatitis B- and C-coinfected persons treated with directly acting antiviral agents: results from ERCHIVES. Clin Infect Dis. 2019;71:664. PubMed Central Google Scholar
Chen Q, Li Q, Li D et al. Association between liver fibrosis scores and the risk of mortality among patients with coronary artery disease. Atherosclerosis. 2020;299:45–52. CASPubMed Google Scholar
Vinholt PJ, Hvas AM, Frederiksen H et al. Platelet count is associated with cardiovascular disease, cancer and mortality: a population-based cohort study. Thromb Res. 2016;148:136–142. CASPubMed Google Scholar
Yang M, Pan Y, Li Z et al. Platelet count predicts adverse clinical outcomes after ischemic stroke or TIA: subgroup analysis of CNSR II. Front Neurol. 2019;10:370. PubMedPubMed Central Google Scholar
Lassale C, Curtis A, Abete I et al. Elements of the complete blood count associated with cardiovascular disease incidence: findings from the EPIC-NL cohort study. Sci Rep. 2018;8:3290. PubMedPubMed Central Google Scholar
Lee H, Shin DW, Lee TH et al. Association between change in serum aminotransferase and mortality: a nationwide cohort study in Korea. Medicine (Baltimore). 2016;95:e3158. CASPubMedPubMed Central Google Scholar
Unalp-Arida A, Ruhl CE. Noninvasive fatty liver markers predict liver disease mortality in the U.S. population. Hepatology. 2016;63:1170–1183. CASPubMed Google Scholar
Choi KM, Han K, Park S et al. Implication of liver enzymes on incident cardiovascular diseases and mortality: a nationwide population-based cohort study. Sci Rep. 2018;8:3764. PubMedPubMed Central Google Scholar
Peleg N, Issachar A, Sneh Arbib O et al. Liver steatosis is a strong predictor of mortality and cancer in chronic hepatitis B regardless of viral load. JHEP Rep. 2019;1:9–16. PubMedPubMed Central Google Scholar